Successful early development involves financial backing, having the right team in place to get the job done, and reaching critical milestones such as IND approval and proof of concept. You need to show your science works and has safe and beneficial medical potential. That way, you can achieve a good return on your investment and reach a buyer that can fully develop your product and deliver it to patients.
PAREXEL offers flexible, tailored expertise to drive product value in early stage development. Our experts have been in your shoes and know what it takes to build early stage product value.
- Market Analysis and Product Classification
- Product Development Strategy and Plan
- Regulatory Liaison and Pre-IND Agency Meetings
- Preclinical and Bio-analytical Analysis
- IND Preparation and Submissions
- CMC and Manufacturing Process
- Clinical Trial Manufacturer GMP Audits
- Integrated Early Phase Development (Healthy Volunteers and Patients)
- Phase I and II Clinical Trial Consulting and Development
- Proof of Concept
- Product Positioning
Featured Experts: Dr. Bruce Babbitt, Cecil Nick, Dr. Larry Ereshefsky,
Dr. Malek Bajbouj, Dr. Matthias Grossman, Dr. James Wong, Dr. John Lambert, Dr. Herman Scholtz
Contact us today to discuss your key to product development success.
